1 | kleijnen systematic reviews ksr | | | | | | | 11 | 1.73% |
2 | an independent research company | | | | | | | 7 | 1.10% |
3 | of research evidence in | | | | | | | 6 | 0.94% |
4 | assessments of research evidence | | | | | | | 6 | 0.94% |
5 | systematic reviews ksr independent | | | | | | | 6 | 0.94% |
6 | systematic reviews ksr ltd | | | | | | | 6 | 0.94% |
7 | that produces and disseminates | | | | | | | 5 | 0.78% |
8 | research evidence in healthcare | | | | | | | 5 | 0.78% |
9 | analyses and health technology | | | | | | | 5 | 0.78% |
10 | costeffectiveness analyses and health | | | | | | | 5 | 0.78% |
11 | reviews costeffectiveness analyses and | | | | | | | 5 | 0.78% |
12 | systematic reviews costeffectiveness analyses | | | | | | | 5 | 0.78% |
13 | company that produces and | | | | | | | 5 | 0.78% |
14 | reviews ksr ltd is | | | | | | | 5 | 0.78% |
15 | research company that produces | | | | | | | 5 | 0.78% |
16 | independent research company that | | | | | | | 5 | 0.78% |
17 | analyses health technology assessments | | | | | | | 5 | 0.78% |
18 | ksr independent research company | | | | | | | 5 | 0.78% |
19 | reviews ksr independent research | | | | | | | 5 | 0.78% |
20 | systematic reviews analyses health | | | | | | | 4 | 0.63% |
21 | research company systematic reviews | | | | | | | 4 | 0.63% |
22 | independent research company systematic | | | | | | | 4 | 0.63% |
23 | is an independent research | | | | | | | 3 | 0.47% |
24 | evidence in healthcare ksr | | | | | | | 3 | 0.47% |
25 | kleijnen systematic reviews | | | | | | | 3 | 0.47% |
26 | of commissioners including the | | | | | | | 3 | 0.47% |
27 | national institute for health | | | | | | | 3 | 0.47% |
28 | reviews analyses health technology | | | | | | | 3 | 0.47% |
29 | in europe and for | | | | | | | 3 | 0.47% |
30 | institutes in europe and | | | | | | | 3 | 0.47% |
31 | commissioners including the national | | | | | | | 2 | 0.31% |
32 | nice similar institutes in | | | | | | | 2 | 0.31% |
33 | ltd is an independent | | | | | | | 2 | 0.31% |
34 | cookies 3rd party cookies | | | | | | | 2 | 0.31% |
35 | so that we can | | | | | | | 2 | 0.31% |
36 | europe and for pharmaceutical | | | | | | | 2 | 0.31% |
37 | find out more about | | | | | | | 2 | 0.31% |
38 | disseminates systematic reviews costeffectiveness | | | | | | | 2 | 0.31% |
39 | similar institutes in europe | | | | | | | 2 | 0.31% |
40 | care excellence nice similar | | | | | | | 2 | 0.31% |